Category archives for: Business

Director of MARTIN MIDSTREAM PARTNERS L.P. (U.S.: Nasdaq:MMLP), Taylor Sharon L, buys 416 shares worth $1,212

According to MARTIN MIDSTREAM PARTNERS L.P.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 10:56 AM, company Director, Taylor Sharon L disclosed buying 416 shares at a cost of $2.91. At the time of this transaction (Jan 11), this trade was worth $1,212 in total. […]

Chief Medical Officer of MARTIN MIDSTREAM PARTNERS L.P. (U.S.: Nasdaq:MMLP), Martin Ruben S, buys 485 shares worth $1,413

According to MARTIN MIDSTREAM PARTNERS L.P.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 10:56 AM, company Chief Medical Officer, Martin Ruben S disclosed buying 485 shares at a cost of $2.91. At the time of this transaction (Jan 11), this trade was worth $1,413 […]

Director of Anixa Biosciences Inc (U.S.: Nasdaq:ANIX), Titterton Lewis H Jr, buys 2,000 shares worth $6,400

According to Anixa Biosciences Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:54 AM, company Director, Titterton Lewis H Jr disclosed buying 2,000 shares at a cost of $3.20. At the time of this transaction (Jan 11), this trade was worth $6,400 in total. […]

Chief Executive Officer of AMN HEALTHCARE SERVICES INC (U.S.: NYSE:AMN), Salka Susan R, sells 14,309 shares worth $1,566,361

According to AMN HEALTHCARE SERVICES INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:28 PM, company Chief Executive Officer, Salka Susan R disclosed selling 14,309 shares at a cost of $109.47. At the time of this transaction (Jan 10), this trade was worth $1,566,361 […]

Chief Accounting Officer of bluebird bio, Inc. (U.S.: Nasdaq:BLUE), Whitten Jessica, sells 279 shares worth $2,690

According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:16 PM, company Chief Accounting Officer, Whitten Jessica disclosed selling 279 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $2,690 in total. […]

Chief Operating and of bluebird bio, Inc. (U.S.: Nasdaq:BLUE), Cole Jason, sells 3,387 shares worth $32,659

According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Chief Operating and, Cole Jason disclosed selling 3,387 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $32,659 in total. […]

Chief Operating and of bluebird bio, Inc. (U.S.: Nasdaq:BLUE), Cole Jason, sells 1,584 shares worth $14,893

According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Chief Operating and, Cole Jason disclosed selling 1,584 shares at a cost of $9.40. At the time of this transaction (Jan 10), this trade was worth $14,893 in total. […]

Director of bluebird bio, Inc. (U.S.: Nasdaq:BLUE), Leschly Nick, sells 5,068 shares worth $48,869

According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Director, Leschly Nick disclosed selling 5,068 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $48,869 in total. As of […]

Director of bluebird bio, Inc. (U.S.: Nasdaq:BLUE), Leschly Nick, sells 2,369 shares worth $22,274

According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Director, Leschly Nick disclosed selling 2,369 shares at a cost of $9.40. At the time of this transaction (Jan 10), this trade was worth $22,274 in total. As of […]

President and CEO of bluebird bio, Inc. (U.S.: Nasdaq:BLUE), Obenshain Andrew, sells 4,683 shares worth $45,156

According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company President and CEO, Obenshain Andrew disclosed selling 4,683 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $45,156 in total. […]

Featured Press Releases

Photo Gallery

Log in